APOE ε2/ε3 (n = 4) is associated with reduced AD risk (odds ratio [OR] 0.6), and APOE ε2/ε4 (n = 1) is associated with increased AD risk (OR 2.6; Figure 3C).49 This evidence concerns the gene APOE and Alzheimer disease.